Integrity Alliance’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774K Buy
6,061
+129
+2% +$16.1K 0.03% 348
2025
Q4
$723K Buy
+5,932
New +$680K 0.03% 375
2025
Q2
Sell
-2,913
Closed -$236K 674
2025
Q1
$236K Buy
+2,913
New +$260K 0.01% 542

Other funds holding XBI

Integrity Alliance's XBI Position: Q1 2026 in Review

Integrity Alliance increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.2% in Q1 2026, buying an estimated $16.1K and bringing the position to 6,061 shares worth $774K. The position accounts for 0.03% of the portfolio, ranked #348.

Integrity Alliance first reported a position in XBI in Q1 2025 and has held it in 3 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Integrity Alliance held 6,061 shares of State Street SPDR S&P Biotech ETF worth $774K as of Q1 2026.
  • Integrity Alliance bought 129 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $16.1K.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Integrity Alliance's portfolio in Q1 2026, its #348 holding.
  • Integrity Alliance first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 3 quarters since.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.